Table 7.

Association of AmtRNA with clinically relevant SLE autoantibodies.

		AmtRNA
		IgG	IgM
aCL	IgG	(–) 0.26 ± 0.43	(–) 0.34 ± 0.40
		(+) 0.42 ± 0.91	(+) 0.56 ± 0.90
		p = 0.14	p = 0.01
	IgM	(–) 0.26 ± 0.43	(–) 0.33 ± 0.38
		(+) 0.53 ± 0.95	(+) 0.86 ± 1.43
		p = 0.19	p = 0.002
Lupus anticoagulant		(–) 0.25 ± 0.45	(–) 0.35 ± 0.40
		(+) 0.40 ± 0.67	(+) 0.57 ± 0.98
		p = 0.20	p = 0.06
Anti-dsDNA antibodies		(–) 0.19 ± 0.28	(–) 0.34 ± 0.41
		(+) 0.70 ± 0.71	(+) 0.55 ± 0.27
		p < 0.0001	p = 0.10

Values presented as median ± IQR and Wilcoxon test p-value for patient positives (+) or negatives (–) for each variable.

aCL, anti-cardiolipin antibodies; AmtRNA, anti-mitochondrial RNA antibodies; Anti-dsDNA, antibodies against double-stranded DNA. Data in bold are statistically significant (p < 0.05).